Lymphoma clinical trials
Showing 51–99 of 99 active trials. Describe your situation to see which ones look like a fit.
- Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies
- IlluminOss Photodynamic Bone Stabilization System for the Treatment of Impending and Actual Pelvis Fractures
- Pediatric PET/MR Image Registry
- Umbilical Cord Blood Transplantation From Unrelated Donors
- Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
- Registry of Older Patients With Cancer
- Childhood Cancer Survivor Study
- Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
- Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
- An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers
- Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy
- Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial
- Exercise as an Immune Adjuvant for Allogeneic Cell Therapies
- Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR)
- Increasing Resiliency Among Early Post-Treatment Lymphoma Survivors
- Living Well With Lymphoma
- Virtual Reality During Lumbar Punctures in Acute Lymphoblastic Leukemia
- DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics
- Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy
- Remote Monitoring and Symptom Management Digital Application
- Take the Reins: The Effects of Nutrient Timing on Cancer-related Fatigue
- Coping Skills Training for Symptom Management and Daily Steps (Step Up)
- Stereotactic MRI-guided Focused Ultrasound Mesencephalotomy
- Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
- A Collaborative Intervention for Improving Cancer Pain Management in Cancer Survivors
- Improving Health Insurance Literacy Among Young Adult Cancer Survivors
- Pilot Study of Fisetin to Improve Fatigue Among Older Adult Cancer Survivors
- HEME Home Transfusion Program
- Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
- Mosaic Trial for Stem Cell Transplant Recipients
- Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
- Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
- A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
- Sotagliflozin as Prevention of Anthracycline-Related Cardiotoxicity
- Navigating the Clinical Research Process for Lymphoma
- Rutgers University Study of the Genetics of Blood Cancers
- A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship
- Bone Marrow Grafting for Leukemia and Lymphoma
- Anti-viral T-cell Therapy by Gamma Capture
- Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing
- Clinical Trial to Treat Stage IV Cancer Patients
- Quest to Analyze One Thousand Humans Meditating
- Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event
- Study Assessing MTD, Safety, Tolerability, PK and Anti-tumor Effects of LNS8801alone and With Pembrolizumab
- Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- A Comparator Study of a Tasso Device Blood Sample to Traditional Venous Blood Sample for CBC
- Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
- Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.